Stony Brook Offers Advanced Treatment for Mesothelioma Patients
Stony Brook Cancer Center specializes in treating pleural and peritoneal mesothelioma with advanced surgical techniques. The center’s surgical oncology team uses minimally invasive and robotic approaches whenever possible to reduce recovery time.
Dr. Georgios V. Georgakis, a surgical oncologist at Stony Brook, brings specialized expertise in peritoneal mesothelioma treatment. He performs complex procedures including cytoreductive surgery combined with heated chemotherapy. His focus on robotic and minimally invasive techniques helps patients recover faster.
The center advances mesothelioma care through active research programs testing new treatment combinations. This academic medical center approach gives people with mesothelioma access to both experienced specialists and emerging therapies.
Treatment Options for Peritoneal Mesothelioma at Stony Brook
Stony Brook Cancer Center is the only facility on Long Island offering cytoreductive surgery with HIPEC. The center has performed this complex procedure since the 1990s with an established track record.
The procedure combines two approaches to treat peritoneal mesothelioma. Cytoreductive surgery removes all visible tumors from the abdominal cavity. Surgeons then deliver heated chemo directly into the abdomen during the same operation. The heat helps the chemo penetrate remaining mesothelioma cells more effectively than standard intravenous treatment.
Stony Brook’s multidisciplinary team also offers systemic chemo, radiation therapy and immunotherapy for mesothelioma patients. The surgical oncology division works closely with medical oncologists, radiation oncologists and pathologists to coordinate comprehensive care. Treatment plans may combine surgery with additional therapies based on disease progression and patient response.
Stony Brook Cancer Center Secures Key Accolades
Stony Brook Cancer Center earns Commission on Cancer accreditation from the American College of Surgeons. This designation recognizes comprehensive cancer programs that meet strict standards for patient care, research and education.
The American College of Radiology grants accreditation to the center’s radiation oncology program. This certification verifies that the team meets national standards for safety, quality and technical expertise.
Stony Brook Cancer Center also holds FACT Accreditation for its stem cell transplant program. This accreditation reflects adherence to international standards for cellular therapy procedures.
Clinical Trial Access at Stony Brook
Stony Brook Cancer Center conducts cancer clinical trials with funding from the National Institutes of Health, the National Cancer Institute and pharmaceutical companies. The center offers more than 100 trials across different cancer types.
Mesothelioma patients interested in clinical trial participation can discuss options with their oncology team. Clinical trial coordinators review eligibility and match patients with appropriate studies when available. Participation in any trial is completely voluntary. Reach out to our Patient Advocates to learn more about clinical trial enrollment and available studies.